China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement
BEIJING, Aug. 24, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company's board of directors (the "Board") has received a letter da...
China Biologic Products to Report Second Quarter 2018 Financial Results
BEIJING, July 27, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its second quarter 2018 financial results ...
China Biologic Products to Report Second Quarter of 2017 Financial Results
BEIJING, July 19, 2017 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release second quarter of 2017 financial results onWednesda...
